Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Cytoplasmic aggregation of misfolded alpha-synuclein (α-Syn) characterizes synucleinopathies like Parkinson's disease (PD).
• The exact pathogenic role of α-Syn in PD remains unclear, though fibrillar and oligomeric forms are suspected contributors to toxicity and disease spread.
• Oligomeric α-Syn species are considered particularly neurotoxic, but their structural heterogeneity and transient nature complicate study.

Purpose of the Study:

• To review recent advances in understanding the formation and role of α-Syn oligomers in PD pathogenesis.
• To summarize diverse α-Syn oligomeric species and their potential neurotoxic mechanisms.
• To discuss therapeutic strategies targeting α-Syn for PD and outline future research directions.

Main Methods:

• Literature review of recent scientific publications.
• Synthesis of current knowledge on α-Syn oligomer formation and function.
• Analysis of proposed mechanisms of α-Syn-mediated neurotoxicity.

Main Results:

• α-Syn oligomers are key players in PD pathogenesis, exhibiting diverse structures and toxic effects.
• Multiple mechanisms contribute to α-Syn oligomer-induced neurotoxicity.
• Targeting α-Syn presents a promising therapeutic avenue for PD.

Conclusions:

• Understanding α-Syn oligomer dynamics is crucial for elucidating PD pathology.
• Further research into α-Syn oligomer structure-function relationships can guide therapeutic development.
• Targeting α-Syn offers a viable strategy for novel PD treatments.